Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06577519 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)

StatusRecruiting
PhasePhase 3
Started2024-09-06
View on ClinicalTrials.gov ↗

Amendment history

2026-07-23
Study Status v2
Re-verified, no change to tracked fields
2024-09-28
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2024-09-15→confirmed 2024-09-06
Study sitesdetails revised at 1 of 1 site
2024-08-28
Original filing
This is a multi-center, randomized, double-blind, double-dummy, parallel-controled, phase III trial, aiming to evaluate the effectiveness and safety of long-term continuous administration of Vicagrel capsules in ACS patients undergoing PCI.
Trial Details
NCT Number NCT06577519
Lead Sponsor Jiangsu vcare pharmaceutical technology co., LTD
Conditions Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Enrollment 1,000 participants
Start Date 2024-09-06
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-27